Summary & Overview
HCPCS C9768: Endoscopic Ultrasound-Guided Hepatic Portosystemic Pressure Measurement
HCPCS Level II code C9768 represents an endoscopic ultrasound-guided direct measurement of the hepatic portosystemic pressure gradient, reported in addition to the primary endoscopic procedure. This code captures a specialized diagnostic vascular pressure assessment used in evaluation and management of portal hypertension and related hepatic vascular conditions. Nationally, the procedure is clinically significant because it provides direct hemodynamic data that can influence prognostication and treatment planning for patients with suspected or known portal hypertension.
Key payers included in the review are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find an overview of the clinical context for the procedure, coding scope, and the types of settings where the service is typically delivered. The publication summarizes coverage considerations and common billing modifiers and identifies relevant operational benchmarks where available. It also outlines what clinicians and billing teams need to document to support reporting of this add-on diagnostic service and highlights areas where payers commonly request additional justification.
This national-focused summary is intended for healthcare administrators, coding and billing staff, and clinicians involved in hepatology and advanced endoscopy.
Billing Code Overview
HCPCS Level II code C9768 describes endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method. This service captures the direct assessment of the pressure difference between the portal and systemic (hepatic venous) circulations performed using endoscopic ultrasound guidance.
-
Service type: Diagnostic vascular pressure measurement performed via endoscopic ultrasound
-
Typical site of service: Hospital-based endoscopy suite or outpatient endoscopy center
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with a history of chronic liver disease and suspected portal hypertension is referred for endoscopic ultrasound (EUS) evaluation. Clinical indications include refractory ascites, variceal bleeding, or abnormal liver synthetic function with unexplained portal hypertension on imaging. The patient undergoes sedation in an endoscopy suite or ambulatory surgical center; informed consent includes risks of EUS and transhepatic puncture. An endosonographer performs EUS to visualize the left and right portal venous system and hepatic veins. Under EUS guidance, a fine needle is advanced through the gastric or duodenal wall into the liver parenchyma to access a portal vein and a hepatic vein (or inferior vena cava), and direct pressure measurements are taken to calculate the hepatic portosystemic pressure gradient (HVPG). The procedure may be billed in addition to the primary EUS procedure using billing code C9768. Typical monitoring includes continuous hemodynamics and post-procedure observation for bleeding or bile leak. Typical sites of service are hospital-based endoscopy units, ambulatory surgery centers, or specialized endoscopy suites where EUS and invasive pressure monitoring are available.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than usual for the primary EUS procedure and documentation supports increased complexity. |